Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
ADA 2026 5 - 8 June 2026

CGM-based metrics in insulin-naive adults with T2D receiving IcoSema vs glargine U100: post hoc analysis of COMBINE 4

Authors :

Concetta Irace1; Raluca Maltesen2; Laura Pletsch-Borba3; Thaís M Pagliaro Rocha3; Yasuo Terauchi4; Chantal Mathieu5

Affiliations
View Details Hide Details
This is the logo of the provider
{{ getPageNum(PDFPage) }}
Download .PDF
Keywords
Diabetes
Congress poster
Amylin
IcoSema (Icodec Semaglutide)
PHASE 3 (RCT)